A Palo Alto company could be poised to potentially change the existing laboratory testing model for consumers, the San Francisco Business Times reports. 

Theranos has been offering tests based on a pin prick's worth of blood in Walgreens in the Phoenix area and one in Palo Alto, California for routine analysis such as blood cholesterol levels and diabetes, without a physician's order.